Prostate cancer diagnosis: Health Triage in Florence for the Tuscan GOM network meeting.

On March 26–27, 2026, Health Triage will participate as a sponsor in the course “Diagnosis, Staging and Multidisciplinary Management of Prostate Cancer: The Tuscan GOM Network in Action.” The event, which will take place at the Grand Hotel Mediterraneo in Florence, represents a strategic opportunity for discussion among coordinators of regional oncology networks, aimed at…

Read more

Breast screening and AI: Francesca Caumo (GISMa) explains the value of the Breast AI study in La Repubblica

Artificial Intelligence is entering the core of organized mammographic screening. In La Repubblica, within the Health special section, Dr. Francesca Caumo, Vice President of GISMa (Italian Group for Mammographic Screening), discusses the challenges and opportunities related to integrating new technologies into prevention pathways. At the center is the large prospective multicenter study, Breast AI, born…

Read more

Breast screening: partnership between the Italian Mammography Screening Group (GISMa) and Health Triage for one of the most innovative European studies on the use of Artificial Intelligence

An agreement has been signed for a clinical validation study involving 75,000 women: the goal is to strengthen the national prevention programme through “intelligent triage”, which optimises radiologists’ work and accelerates diagnoses. TURIN, 12 February 2026 – With the introduction of new guidelines on AI applied to prevention at the end of 2025, Italy strengthens…

Read more

BREAST CANCER SCREENING AND ARTIFICIAL INTELLIGENCE: A TURNING POINT IN THE ITALIAN NATIONAL INSTITUTE OF HEALTH GUIDELINES

The update of the national Guidelines on 23 December 2025 marks a turning point for cancer prevention in Italy. For the first time, the national panel, adopting the GRADE methodology, issued a conditional recommendation in favor of using an AI-based triage strategy for reading mammograms within breast cancer screening programs. Question 3: a strategic innovation…

Read more

Tomosynthesis and Artificial Intelligence: the ASSURE study shows a +21.6% increase in breast cancer detection

An analysis of over half a million women in the United States confirms that artificial intelligence, applied to tomosynthesis (3D mammography), improves cancer detection without increasing false positives. The results reinforce a key premise: to make screening more effective, it is not enough to “see more,” but to see better. This is the logic behind…

Read more

Cancer Research Horizons e Royal Surrey collaborano con Health Triage per migliorare lo screening del tumore al seno con l’AI

LONDRA e GUILDFORD, Regno Unito, e TORINO, Italia, 21/05/2025 – Cancer Research Horizons e il Royal Surrey NHS Foundation Trust hanno annunciato una collaborazione con Health Triage, una start-up italiana specializzata in intelligenza artificiale per la diagnostica medica, con l’obiettivo di migliorare lo screening del tumore al seno utilizzando i dati del database OPTIMAM Medical…

Read more

Health Triage and GISMa join forces for early detection of breast cancer

Health Triage S.r.l. and GISMa (Gruppo Italiano Screening Mammografico) have formalized a new collaboration aimed at improving mammography screening programs through the application of artificial intelligence. The aim of this collaboration is to evaluate the effects of a technology specialized in identifying negative cases in screening. Luckily, a large number of screening mammograms are negative,…

Read more